At the Goldman Sachs 47th Annual Global Healthcare Conference held on June 9, 2026, Christopher Hite, Chairman of Royalty Pharma plc (RPRX), discussed the company's evolution over the past 30 years. Founded by Pablo Legorreta, Royalty Pharma has developed a unique business model focused on acquiring royalty streams from various sectors, including universities, hospitals, and biotech companies. Hite explained that the company's foundational premise is to address the fragmented nature of innovation within the healthcare sector. By acquiring these royalty streams, Royalty Pharma provides upfront capital to institutions, allowing them to reinvest in further research and development. This model not only supports innovation but also shifts the commercial risk associated with these assets to Royalty Pharma. Hite's presentation aimed to inform potential investors about the company's strategic advantages and growth potential in the healthcare market, particularly as it celebrates its 30th anniversary.